Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 15905305)

Published in Ann Oncol on May 19, 2005

Authors

W J Gradishar1, S B Wedam, M Jahanzeb, J Erban, S A Limentani, K-T Tsai, S R Olsen, S M Swain

Author Affiliations

1: Northwestern University Feinberg School of Medicine, Chicago, IL, USA. swains@mail.nih.gov

Associated clinical trials:

IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer (Neonab) | NCT01830244

Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer (PELICAN) | NCT03515798

Articles by these authors

(truncated to the top 100)

Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol (2005) 3.62

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. Br J Haematol (2004) 3.49

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol (2010) 2.94

Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer. Ann Oncol (2014) 2.29

Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. J Clin Oncol (1992) 1.89

A practical guide to the evaluation and treatment of hemophilia. Blood (1994) 1.88

The LS locus of pea encodes the gibberellin biosynthesis enzyme ent-kaurene synthase A. Plant J (1997) 1.82

Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study. Br J Cancer (2006) 1.71

Identification of a negative regulator of gibberellin action, HvSPY, in barley. Plant Cell (1998) 1.58

Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res (1987) 1.54

Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer (1990) 1.47

P-selectin and E-selectin. Distinct but overlapping leukocyte ligand specificities. J Biol Chem (1992) 1.44

Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis (1995) 1.38

Tamoxifen and contralateral breast cancer: the other side. J Natl Cancer Inst (2001) 1.30

Cancer gene discovery using digital differential display. Cancer Res (2000) 1.27

Internode length in Pisum : A new, slender mutant with elevated levels of C19 gibberellins. Planta (1992) 1.24

Tamoxifen: the long and short of it. J Natl Cancer Inst (1996) 1.23

Ectopic expression of the tetratricopeptide repeat domain of SPINDLY causes defects in gibberellin response. Plant Physiol (2001) 1.15

Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. Ann Oncol (2013) 1.08

The role of SPY and its TPR domain in the regulation of gibberellin action throughout the life cycle of Petunia hybrida plants. Plant J (2001) 1.02

Tamoxifen-induced steatohepatitis. Ann Intern Med (1995) 1.00

The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue. Hum Pathol (1990) 0.99

Comparison of the effects of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells. J Infect Dis (1996) 0.97

Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer. Clin Transplant (2000) 0.95

Heterogeneous expression of erbB-2 messenger RNA in human breast cancer. Cancer Res (1989) 0.93

Immunoaffinity purification of factor IX (Christmas factor) by using conformation-specific antibodies directed against the factor IX-metal complex. Proc Natl Acad Sci U S A (1985) 0.91

Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer. Am Surg (1990) 0.87

Treatment of patients with inflammatory breast cancer. Important Adv Oncol (1989) 0.84

Results of a trial with topotecan dose escalation and concurrent thoracic radiation therapy for locally advanced, inoperable nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys (1996) 0.83

Adjuvant therapy in early breast cancer. Am Fam Physician (1991) 0.83

Phase II study of oral etoposide for patients with advanced breast cancer. Cancer (1995) 0.81

Tumor markers: should we or shouldn't we? Cancer J (2001) 0.81

Adjuvant chemotherapy for breast cancer: an update. Semin Oncol (2001) 0.81

Does CDKN2A loss predict palbociclib benefit? Curr Oncol (2015) 0.80

HER-2/neu expression in archival non-small cell lung carcinomas using FDA-approved Hercep test. Anticancer Res (2000) 0.80

Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibility. Pharmacogenetics (1993) 0.80

[The occurrence of circadian rhythm in respiration in healthy persons and in patients with bronchial asthma]. Cas Lek Cesk (1989) 0.80

Doxorubicin-induced cardiomyopathy. N Engl J Med (1999) 0.80

Glutamic acid 203 of the cAMP-dependent protein kinase catalytic subunit participates in the inhibition by two isoforms of the protein kinase inhibitor. J Biol Chem (1994) 0.79

Modifications of a conserved regulatory network involving INDEHISCENT controls multiple aspects of reproductive tissue development in Arabidopsis. New Phytol (2012) 0.79

Use of variations in natural nitrogen isotope abundance for environmental studies: a questionable approach. Science (1972) 0.79

Phase I trial of dasatinib and ixabepilone in patients with solid tumors. Invest New Drugs (2012) 0.79

Hepatic perfusion changes in patients with cirrhosis indices of hepatic arterial blood flow. Clin Nucl Med (1999) 0.77

The importance of local-regional radiotherapy with conventional or high-dose chemotherapy in the management of breast cancer patients with > or = 10 positive axillary nodes. Int J Radiat Oncol Biol Phys (1999) 0.77

Decreased thyroid function and high plasma prolactin levels in rats of the Buffalo strain. Endocrinology (1978) 0.77

Oral vinorelbine (Navelbine) in the treatment of advanced non-small cell lung cancer: a preliminary report. Semin Oncol (1994) 0.77

Update on adjuvant chemotherapy for early breast cancer. Oncology (Williston Park) (2000) 0.76

Acquired free protein S deficiency associated with multiple myeloma: a case report. Am J Hematol (1996) 0.76

Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study. Breast Cancer Res Treat (2014) 0.75

In situ or localized breast cancer--how much treatment is needed? N Engl J Med (1993) 0.75

Magnetic tape recording of scintillation scan data using a commercial apparatus. Radiobiol Radiother (Berl) (1972) 0.75

Controversies in the treatment of cancer of the breast. Annu Rev Med (1987) 0.75

[Clinical significance of radionuclide ventriculography in patients with myocardial infarct]. Vnitr Lek (1985) 0.75

[Study of uteroplacental circulation using 113mIn in physiological pregnancy in the 3d trimester]. Cesk Gynekol (1986) 0.75

[Equipment for the measurement of I-131 storage in the thyroid gland in accordance with recommendations by the IAEA]. Radiobiol Radiother (Berl) (1967) 0.75

[Circadian study of ventilation in patients with bronchial asthma in practice]. Cas Lek Cesk (1985) 0.75

The influence of actinomycin D on the activity of delta-aminolaevulinic acid synthetase and dehydratase in the liver of mice and rats treated by griseofulvin. Physiol Bohemoslov (1977) 0.75

[A dynamic phantom for quality control of ventriculography examinations]. Cesk Radiol (1989) 0.75

Hormonal manipulation in the adjuvant treatment of breast cancer. Important Adv Oncol (1993) 0.75

[About the possibility of fallopian tubes patency evaluations by means of 99mTc-pertechnetate and comparison of radiation loads due to radioisotopic and x-ray examinations (author's transl)]. Cesk Gynekol (1981) 0.75

Examination of uteroplacental blood flow with 113m In (in physiological pregnancies). Acta Univ Palacki Olomuc Fac Med (1986) 0.75

[Prostaglandin F2 alpha and acetylcholine in pollen allergy]. Cas Lek Cesk (1982) 0.75

[New collimators for the scintiscanner Szintikart of type MB-8100 made in Hungary (author's transl)]. Cesk Radiol (1982) 0.75

The role of primary chemotherapy in early breast cancer. Semin Oncol (1996) 0.75

[Free protoporphyrin in murine and rat erythrocytes. Study of experimental porphyrias induced through the administration of griseofulvin to mice and 3,5 diethoxycarbonyl-1,4 dihydro-2,4,6 trimethylpyridine (DDC) to rats]. Cas Lek Cesk (1977) 0.75

[A study trip to the People's Republic of China]. Cas Lek Cesk (1989) 0.75

[5-year experience with the Heimox system in the treatment of patients with chronic respiratory insufficiency]. Cas Lek Cesk (2002) 0.75

Reimbursement for solid tumor autologous bone marrow transplantation trials: a strategy for ensuring continuation of a promising therapy. Cancer Invest (1991) 0.75

Detectable inhibition of heparin-binding growth factor activity in sera from patients treated with pentosan polysulfate. J Natl Cancer Inst (1993) 0.75

[Circadian study of ventilation in patients with bronchial asthma in ambulatory care]. Cas Lek Cesk (1985) 0.75

Health plan ordered to pay high penalty. J Health Care Benefits (1994) 0.75

[A device for measuring contamination of hands in work places with open radiation sources]. Acta Univ Palacki Olomuc Fac Med (1989) 0.75

Surveillance systems and public health priority actions. Bull Int Union Tuberc Lung Dis (1990) 0.75

Simple models of pharmacological protection against induced bronchial obstruction. Czech Med (1980) 0.75

Therapy of patients with metastatic breast cancer with 5-fluorouracil, leucovorin and carboplatin. Anticancer Drugs (1992) 0.75

Cytochemistry of DNA in the leukocytes of the mentally ill. Act Nerv Super (Praha) (1980) 0.75

[Equipment and procedures for the control of detection parameters of scintillation cameras]. Cesk Radiol (1984) 0.75

Indication and clinical application of radionuclide hysterosalpingography using 99mTc-pertechnetate. Acta Univ Palacki Olomuc Fac Med (1984) 0.75

Measurement of regional uteroplacental blood flow. Acta Univ Palacki Olomuc Fac Med (1988) 0.75

Hormone replacement therapy in women with a history of breast carcinoma. Hematol Oncol Clin North Am (1994) 0.75

[A method for absolute quantification of 67Ga-citrate accumulation in the lungs and its significance in the evaluation of pulmonary sarcoidosis activity]. Cesk Radiol (1988) 0.75

Novel agents: clinical trial design. Semin Oncol (2001) 0.75

[Uteroplacental blood flow in various parts of the placenta]. Cesk Gynekol (1987) 0.75

Early diagnosis of artificial arterial aneurysm after kidney transplantation using radioisotope scintigraphy. Acta Univ Palacki Olomuc Fac Med (1993) 0.75

The treatment of metastatic breast cancer with 5-fluorouracil and leucovorin. Adv Exp Med Biol (1988) 0.75

[Chronotherapy of bronchial asthma with Berotec and Berodual]. Cas Lek Cesk (1983) 0.75

[Circadian ventilation in healthy subjects and in patients with bronchial asthma (author's transl)]. Cas Lek Cesk (1982) 0.75

The benefits of support group participation to lung cancer survivors--an evaluation. Clin Lung Cancer (1999) 0.75

Creatine supplementation delays onset of fatigue during repeated bouts of sprint running. Scand J Med Sci Sports (1998) 0.75

[Adverse effects of long-term beclomethasone dipropionate (Becotide) inhalation therapy]. Vnitr Lek (1985) 0.75

[Bronchogenic carcinoma in women]. Cas Lek Cesk (1990) 0.75

Treatment of stage III breast cancer. A panel discussion. Breast Cancer Res Treat (1989) 0.75

Lactation response to ruminally protected methionine and lysine at two amounts of ruminally available nitrogen. J Dairy Sci (1993) 0.75

Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer. J Clin Oncol (1995) 0.75

Performance evaluation of the multidetector gamma counter Multigamma 1260. Acta Univ Palacki Olomuc Fac Med (1981) 0.75

[Possibilities in the use of ambulatory oxygen therapy in practice]. Cas Lek Cesk (1989) 0.75

Pregnancy-induced hypertension and its influence on uteroplacental blood flow. Acta Univ Palacki Olomuc Fac Med (1988) 0.75

[Normal and pathological metabolism of porphyrin]. Cesk Fysiol (1973) 0.75

[Circadian changes in blood gases in patients with bronchial asthma]. Cas Lek Cesk (1985) 0.75

[Hypertension in pregnancy and its effect on uteroplacental blood circulation]. Cesk Gynekol (1987) 0.75